National Comprehensive Cancer Network® Collaborates with CureMD to Enhance Oncology EHR with NCCN Templates®
PLYMOUTH MEETING, PA [May 28, 2019] — The National Comprehensive Cancer Network® (NCCN®) is pleased to announce a collaboration with CureMD, a leading provider of innovative health information systems and services. This partnership aims to integrate the NCCN Chemotherapy Order Templates (NCCN Templates®) into CureMD’s Oncology Electronic Health Record (EHR) system, providing point-of-care access to treatment recommendations and order templates derived from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®).
Enhancing Cancer Care Quality and Safety
“The collaboration with CureMD advances NCCN’s commitment to supporting evidence-based clinical decision support to improve quality, safety, and ultimately outcomes in cancer care,” said C. Lyn Fitzgerald, MJ, Senior Vice President, U.S. & Global Development, NCCN. “We’re enthusiastic about the inclusion of the NCCN Guidelines and NCCN Templates in the CureMD Oncology EHR platform as it will make it easier for clinicians to provide the best evidence- and expert-consensus-based decisions for their patients.”
CureMD is renowned for transforming the administrative and clinical operations of healthcare organizations through their innovative health information systems. Their Oncology EHR is designed to automate provider workflows, ensuring oncology practices and their patients have access to the latest evidence-based treatment information developed by leading experts in the field.
“At CureMD Oncology, we are dedicated to elevating the level of care oncology practices provide to cancer patients. Collaborating with NCCN and providing oncology practices with industry-leading clinical guidelines and treatment regimens through our award-winning Oncology EHR is a resounding example of our dedication to improving care quality,” said Bill Hashmat, CEO, CureMD.
NCCN Guidelines: The Gold Standard in Cancer Care
The NCCN Guidelines are the recognized standard for clinical policy in cancer care, being the most comprehensive and frequently updated clinical practice guidelines available in any area of medicine. Derived directly from these guidelines, the NCCN Templates® include chemotherapy and immunotherapy regimens, supportive care agents, monitoring parameters, and safety instructions. The primary goal of the NCCN Templates is to enhance patient safety by empowering healthcare providers to standardize patient care, reduce medical errors, and effectively manage adverse events.
NCCN continues to expand its library of chemotherapy order templates to promote the safe use of drugs and biologics in cancer care.
For more information about the use of NCCN Content in Health Information Technology, visit NCCN.org/HIT.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of 28 leading cancer centers dedicated to improving and facilitating quality, effective, efficient, and accessible cancer care. NCCN’s mission is to ensure patients live better lives through the leadership and expertise of clinical professionals at NCCN Member Institutions. By defining and advancing high-quality cancer care, NCCN promotes continuous quality improvement and the importance of clinical practice guidelines suitable for use by patients, clinicians, and other healthcare decision-makers worldwide.
The NCCN Member Institutions include:
- Abramson Cancer Center at the University of Pennsylvania, Philadelphia, PA
- Fred & Pamela Buffett Cancer Center, Omaha, NE
- Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
- City of Hope National Medical Center, Duarte, CA
- Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA
- Duke Cancer Institute, Durham, NC
- Fox Chase Cancer Center, Philadelphia, PA
- Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
- Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
- Mayo Clinic Cancer Center, Phoenix/Scottsdale, AZ, Jacksonville, FL, and Rochester, MN
- Memorial Sloan Kettering Cancer Center, New York, NY
- Moffitt Cancer Center, Tampa, FL
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute, Columbus, OH
- O’Neal Comprehensive Cancer Center at UAB, Birmingham, AL
- Roswell Park Comprehensive Cancer Center, Buffalo, NY
- Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO
- St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center, Memphis, TN
- Stanford Cancer Institute, Stanford, CA
- UC San Diego Moores Cancer Center, La Jolla, CA
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
- University of Colorado Cancer Center, Aurora, CO
- University of Michigan Rogel Cancer Center, Ann Arbor, MI
- The University of Texas MD Anderson Cancer Center, Houston, TX
- University of Wisconsin Carbone Cancer Center, Madison, WI
- Vanderbilt-Ingram Cancer Center, Nashville, TN
- Yale Cancer Center/Smilow Cancer Hospital, New Haven, CT
For Clinicians, visit NCCN.org. For Patients and Caregivers, visit NCCN.org/patients. For Media Inquiries, visit NCCN.org/news. Follow NCCN on Twitter @NCCN, Facebook @NCCNorg, and Instagram @NCCNorg.
